Desktop Site
|
02 May 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,611.11
+128.33
+0.17 %
Corporate Announcement
Security Code
500660
Company
GLAXOSMITHKLINE PHARMACEUTICALS LTD.
Exchange Received Time
19/04/2024 12:14:07
Exchange Disseminated Time
19/04/2024 12:14:08
Time Taken
00:00:01
Board Meeting Intimation for Audited Financial Results For Year 31St March 2024 & To Recommend Dividend, If Any |
4/19/2024 12:14:08 PM
GLAXOSMITHKLINE PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve Pursuant to clause 29 & 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), this is to inform you that a meeting of the Board of Directors of our Company will be held on Friday, 17th May 2024, inter-alia, to consider amongst other things, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended 31st March 2024 and to recommend dividend, if any, on the equity shares of the Company.
Attachment
<< Back
Recently Viewed